Peripheral Chemosensitivity
Conditions
Brief summary
This is a randomized, cross over, experimental trial in which carotid body function will be evaluated in 35 healthy subjects during partial muscle relaxation and after recovery from muscle relaxation
Interventions
Rocuronium will be used to induce partial paralysis
Sugamamdex will be used to reverse muscle relaxation
Sponsors
Study design
Eligibility
Inclusion criteria
\* age \> 18 years
Exclusion criteria
* BMI index \> 30 kg/m2 * Known or suspected neuromuscular disorders impairing neuromuscular function; * Allergies to muscle relaxants, anesthetics or narcotics; * A (family) history of malignant hyperthermia or any other muscle disease; * Any neurological or psychiatric illness (including a history of anxiety). * ASA class 3 or higher * Gastro-oesophageal regurgitation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Carotid body function after full recovery of neuromuscular block | 40 minutes after full recovery of neuromuscular block | Carotid body function will be determined by measuring acute hypoxic ventilatory response |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Carotid body function at symptomatic neuromuscular block | 5 minutes after stable partial neuromuscular block | Carotid body function will be determined by measuring acute hypoxic ventilatory response |
| Carotid body function at full recovery of NMB symptoms | 0 minutes after full recovery of neuromuscular block symptoms | Carotid body function will be determined by measuring acute hypoxic ventilatory response |
| Carotid body function after full recovery of neuromuscular block | 20 minutes after full recovery of neuromuscular block symptoms | Carotid body function will be determined by measuring acute hypoxic ventilatory response |
Countries
Netherlands